The Advisory Board Company Reports Fiscal Year 2008 Third Quart...(roup has providedvaluable input regardin...),Health

Outlook for Calendar Year 2008

Although the Company operates on a fiscal year ending March 31, 2008, the following statements summarize the Company's guidance for calendar year 2008. For the twelve months ending December 31, 2008, the Company estimates revenue of approximately $243.0 million. For calendar year 2008, the Company estimates GAAP income from operations of approximately $45.7 million, compared to $39.7 million for calendar year 2007. The Company estimates GAAP earnings per diluted share of approximately $1.86 for calendar year 2008, compared to $1.63 for calendar year 2007. Included in the calendar year 2008 income from operations and earnings per diluted share estimates is approximately $0.49 to $0.52 of share-based compensation and related expense. The Company expects an effective income tax rate of approximately 33.3% for calendar year 2008. For the quarter ending March 31, 2008, the Company estimates revenue of approximately $57.9 million and GAAP earnings per diluted share of approximately $0.46.

Share Repurchase

During the three months ended December 31, 2007, the Company repurchased 156,190 shares of its common stock at a total cost of approximately $10.0 million. To date, the Company has repurchased 4,312,627 shares of its common stock at a total cost of approximately $195.9 million. Repurchases will continue to be made from time to time in open market and privately negotiated transactions subject to market conditions. No minimum number of shares has been fixed. The Company intends to fund its share repurchases with cash on hand and cash generated from operations. At December 31, 2007, the Company had approximately $171.8 million in cash and marketable securities and no debt
'/>"/>